Reagents were obtained as follows: Alexa Fluor (AF) 647 conjugated anti-human CD41 (Bio-Rad, Raleigh, NC, USA), Anti-human CD18 antibody (clone TS1/18), PE anti-human CD11a (BioLegend, San Diego, CA, USA), AF647 conjugated human fibrinogen (ThermoFisher Scientific, Grand Island, NY, USA), Sytox-green (Life Technologies, Grand Island, NY, USA), fibrillar collagen (type I, Chrono-log, PA, USA), Dade Innovin lipidated tissue factor (TF, Siemens, Malvern, PA, USA), D-Phe-Pro-Arg-CMK (PPACK, Santa Cruz Biotechnology, Dallas, TX, USA), corn trypsin inhibitor (CTI, Haematologic Technologies, Essex Junction, VT, USA), tPA (Abcam, Cambridge, MA, USA), H-Gly-Pro-Arg-Pro-OH acetate salt (GPRP, Bachem Americas, Torrance, CA, USA), ε-aminocaproic acid (εACA), ethylenediaminetetraacetic acid (EDTA), and Sigmacote (Sigma, St. Louis, MO, USA).
Af647 conjugated human fibrinogen
Manufactured by Thermo Fisher Scientific
Sourced in United States
AF647 conjugated human fibrinogen is a fluorescently labeled version of the human blood clotting protein fibrinogen. Fibrinogen is a key component in the process of blood clot formation. The AF647 fluorescent dye is covalently attached to the fibrinogen molecule, allowing it to be detected and visualized in various biological applications.
Automatically generated - may contain errors
Lab products found in correlation
Dade innovin lipidated tissue factor tf, by Siemens (2 mentions)
Sigmacote, by Merck Group (2 mentions)
Fibrillar collagen type 1, by Chrono-Log (2 mentions)
ε aminocaproic acid, by Merck Group (1 mentions)
D phe pro arg cmk ppack, by Santa Cruz Biotechnology (1 mentions)
Sytox green, by Thermo Fisher Scientific (1 mentions)
Corn trypsin inhibitor cti, by Prolytix (1 mentions)
H gly pro arg pro oh acetate salt gprp, by Bachem (1 mentions)
2 protocols using af647 conjugated human fibrinogen
1
Multicolor Flow Cytometry of Platelet Activation
2
Evaluating Platelet Function and Coagulation
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Reagents were obtained as follows: Alexa Fluor 488 conjugated anti‐human CD61 (Bio‐Rad), AF647 conjugated human fibrinogen (ThermoFisher Scientific), type I fibrillar collagen (Chrono‐log), Dade Innovin lipidated tissue factor (TF, Siemens), CTI and FXIa (Haematologic Technologies), 4‐(2‐hydroxyethyl)‐1‐piperazineethanesulfonic acid (HEPES; Fisher Scientific), Sigmacote (Sigma), Anti‐FVIII (4A4) and anti‐FIX (BC2; Green Mountain Antibodies), Anti‐TFPI (gA200 hIgG1, Bayer, Whippany), bispecific antibody (emicizumab), reFIX‐V181T variant,25 and a recombinant rIgG4 containing complementarity‐determining regions originally derived from a patient (NB41, as described in van den Brink26 ).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!